Not applicableUnknownNCT04175002What this trial is testingEndometrial Heparin-binding Epidermal Growth Factor ExpressionWho this might be right forGene Abnormality National University of Malaysia 40
Not applicableUnknownNCT02422628What this trial is testingCorrelation Between EGFR Mutation Using cfDNAs and Circulating Tumor Cells in Patients With NSCLCWho this might be right forLung Cancer National Taiwan University Hospital 400
Not applicableWithdrawnNCT04609800What this trial is testingStudy on the Utilization of Cabozantinib in Adult Patients With Advanced or Metastatic Renal Cell Carcinoma (RCC) in 2nd Line Treatment Following Prior Vascular Endothelial Growth Factor (VEGF)-Targeted Therapy Under Real-real Life Clinical Setting in France.Who this might be right forRenal Cell Carcinoma Ipsen
Testing effectiveness (Phase 2)Study completedNCT02132949What this trial is testingA Study Evaluating Pertuzumab (Perjeta) Combined With Trastuzumab (Herceptin) and Standard Anthracycline-based Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced, Inflammatory, or Early-stage Breast CancerWho this might be right forBreast Cancer Hoffmann-La Roche 401
Testing effectiveness (Phase 2)Study completedNCT00554463What this trial is testingG-CSF and Pegfilgrastim in Treating Neutropenia in Patients Undergoing Radiation Therapy and Chemotherapy for Limited Stage Small Cell Lung CancerWho this might be right forLung Cancer Radiation Therapy Oncology Group 5
Large-scale testing (Phase 3)Study completedNCT01846299What this trial is testingTo Assess the Efficacy and Safety of Intravitreal Ranibizumab in People With Vision Loss Due to Macular EdemaWho this might be right forMacular Edema (ME) Novartis Pharmaceuticals 181
Testing effectiveness (Phase 2)Ended earlyNCT00707655What this trial is testingZalutumumab in Combination With Radiotherapy in Head and Neck Cancer Patients Ineligible for Platinum Based ChemotherapyWho this might be right forHead and Neck CancerSquamous Cell Carcinoma Genmab 8
Not applicableStudy completedNCT05061485What this trial is testingThe Effect of Macronutrients on Fibroblast Growth Factor 21 (FGF21) SecretionWho this might be right forHealthy University of Copenhagen 30
Testing effectiveness (Phase 2)Looking for participantsNCT07498478What this trial is testingEfficacy and Safety of Tinengotinib Tablets Combined With Fulvestrant Injection in Patients With HR Positive and HER-2 Negative Recurrent or Metastatic Breast Cancer Who Have Failed Prior TreatmentWho this might be right forBreast Cancer TransThera Sciences (Nanjing), Inc. 94
Not applicableStudy completedNCT00647478What this trial is testingSystem-IGF-1 Pathway and Alzheimer's DiseaseWho this might be right forAlzheimer's DiseaseMild Cognitive ImpairmentCognitive Function 1, Social+1 more Assistance Publique - Hôpitaux de Paris 693
Not applicableStudy completedNCT05399329What this trial is testingStudy to Evaluate Real-world Effectiveness With Palbociclib Plus Endocrine Therapy as First-line/Second-line Treatment for HR+/HER2- Advanced Breast Cancer in JapanWho this might be right forBreast Cancer Pfizer 693
Not applicableStudy completedNCT04236102What this trial is testingKEBI-Cyto Study - Use of the Biocartis IdyllaWho this might be right forPancreatic AdenocarcinomaLung Cancer Royal Cornwall Hospitals Trust 55
Testing effectiveness (Phase 2)Study completedNCT03647488What this trial is testingStudy of Capmatinib and Spartalizumab Combination Therapy vs Docetaxel in Non-small Cell Lung CancerWho this might be right forCarcinoma, Non-Small-Cell Lung Novartis Pharmaceuticals 18
Testing effectiveness (Phase 2)WithdrawnNCT02355431What this trial is testingItacitinib in Combination With Erlotinib in Non Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor (EGFR) Activating MutationsWho this might be right forSolid Tumors and Hematologic MalignancyNSCLC (Non-small Cell Lung Carcinoma) Incyte Corporation
Not applicableTemporarily pausedNCT03193073What this trial is testingAnemia Correction and Fibroblast Growth Factor 23 Levels in Chronic Kidney Disease , and Renal Transplant PatientWho this might be right forAnemia of Chronic Kidney DiseaseEndothelial DysfunctionLeft Ventricular Hypertrophy+1 more Omnia Mohammed Hashem 80
Testing effectiveness (Phase 2)UnknownNCT02812641What this trial is testingNeoadjuvant CCRT With/Without Bevacizumab for Locally Advanced ESCCWho this might be right forStage III Esophageal Squamous Cell Carcinoma National Taiwan University Hospital 50
Large-scale testing (Phase 3)Active Not RecruitingNCT04035486What this trial is testingOsimertinib With or Without Chemotherapy as 1st Line Treatment in Patients With Mutated Epidermal Growth Factor Receptor Non-Small Cell Lung Cancer (FLAURA2)Who this might be right forNon-Small Cell Lung Cancer AstraZeneca 587
Not applicableUnknownNCT05600166What this trial is testingDouble-layer Artificial Dermal Repair Material Combined With Growth Factors is Used for Exposed Tendon WoundsWho this might be right forOpen Wound of Hip With Tendon Involvement Wang xingang 110
Very early researchStudy completedNCT00517062What this trial is testingLow Dose Growth Hormone (GH) on Insulin Sensitivity and Cortisol Production RatesWho this might be right forGrowth Hormone Deficiency Oregon Health and Science University 16
Not applicableStudy completedNCT02595762What this trial is testingTreatment Patterns and Outcomes in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced or Metastatic Breast CancerWho this might be right forMetastatic Breast CancerLocally Advanced Breast Cancer Hoffmann-La Roche 110